IP Library Granted Patent US 10,732,115
Granted Patent B2
US 10,732,115 · App. 14/410,223 · Granted Aug 4, 2020

Mesoporous oxide nanoparticles and methods of making and using same

Inventors: Ulrich Wiesner (Ithaca, NY); Kai Ma (Ithaca, NY)
Assignee: Cornell University
G01N21/6486A61K9/5115A61K9/5146A61K47/6935A61K49/0041A61K49/0093Y10T428/2982
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,732,115
App. No.
14/410,223
Granted
Aug 4, 2020
Kind
B2
Abstract

Mesoporous oxide nanoparticles, compositions comprising such nanoparticle, and methods of making and using such nanoparticles. The nanoparticles (e.g., compositions comprising the nanoparticles) have an average size of less than 15 nm and a narrow size distribution. The nanoparticles can be used in imaging applications and delivery of molecular cargo (e.g., a drug) to an individual.

Claims (36)

1. A composition comprising polyethylene-glycol (PEG) functionalized mesoporous oxide nanoparticles having an average size of 15 nm or less and having only one pore per mesoporous oxide nanoparticle, and at least 90% of the nanoparticles are within 3 nm of the average size, and at least a portion of a non-pore surface of the functionalized mesoporous oxide nanoparticles is at least partially functionalized with polyethylene glycol groups.

2. The composition of claim 1 , wherein the oxide nanoparticles are metal oxide nanoparticles, non-metal oxide nanoparticles, or mixed metal non-metal nanoparticles, or a combination thereof.

3. The composition of claim 1 , wherein at least a portion of the individual nanoparticle non-pore surface and at least a portion of the individual nanoparticle pore surface are functionalized.

4. The composition of claim 3 , wherein the at least a portion of the nanoparticle non-pore surface and the at least a portion of the pore surface have different functionalization.

5. The composition of claim 3 , wherein the at least a portion of the individual nanoparticle non-pore surface is functionalized with a targeting group.

6. The composition of claim 5 , wherein the targeting group is a cancer targeting ligand.

7. The composition of claim 1 , wherein at least a portion of the nanoparticles comprise a molecular cargo.

8. The composition of claim 7 , wherein the molecular cargo is a therapeutic agent or prophylactic agent.

9. The composition of claim 7 , wherein the molecular cargo is covalently bonded to at least a portion of the pore surface and/or non-pore surface of the nanoparticles.

10. The composition of claim 9 , wherein the molecular cargo is covalently bonded to at least a portion of the pore surface via a linker.

11. The composition of claim 10 , wherein the molecular cargo is a fluorescent dye.

12. The composition of 7 , wherein the molecular cargo is sequestered in a pore of the nanoparticles.

13. The composition of claim 7 , wherein the molecular cargo is dispersed in the oxide nanoparticles.

14. The composition of claim 13 , wherein the molecular cargo is a fluorescent dye.

15. The composition of claim 1 , wherein at least 70% of the mesoporous oxide nanoparticles have only one pore per mesoporous oxide nanoparticle.

16. The composition of claim 1 , wherein the PEG functionalized mesoporous oxide nanoparticles have an average size of 10 nm or less.

17. The composition of claim 1 , wherein the PEG functionalized mesoporous oxide nanoparticles have an average size of between 6 nm and 10 nm.

18. The composition of claim 1 , wherein the average size of the PEG functionalized mesoporous oxide nanoparticles is determined by transmission electron microscopy (TEM).

19. A method of making polyethylene glycol (PEG) functionalized mesoporous oxide nanoparticles having an average size of 15 nm or less and having only one pore per mesoporous oxide nanoparticle, and at least 90% of the nanoparticles are within 3 nm of the average size, and at least a portion of a non-pore surface of the functionalized mesoporous oxide nanoparticles is at least partially functionalized with polyethylene glycol groups comprising the steps of:

a) forming a reaction mixture in an aqueous solvent having a basic pH comprising:

i) a surfactant, and

ii) an oxide precursor,

b) holding the reaction mixture at a temperature and for a time such that mesoporous oxide nanoparticles are formed;

c) adding a PEG-functionalized oxide precursor,

d) holding the reaction mixture at a temperature and for a time such that the PEG-functionalized mesoporous oxide nanoparticles are formed;

e) optionally, holding the PEG-functionalized mesoporous oxide nanoparticles at a temperature 50° C. to 95° C. for 0.5 to 24 hours;

f) cooling the reaction mixture to room temperature; and

g) removing the surfactant from the nanoparticles.

20. The method of claim 19 , further comprising the step of functionalizing the nanoparticles.

21. The method of claim 20 , wherein the PEG-functionalized nanoparticles are contacted with a fluorescent dye conjugated oxide precursor such that at least a portion of the pores are functionalized with a fluorescent dye.

22. The method of claim 20 , wherein the PEG-functionalized nanoparticles are contacted with a molecular cargo such that at least a portion of the molecular cargo is sequestered in the pores of the nanoparticles.

23. The method of claim 19 , wherein at least 70% of the mesoporous oxide nanoparticles have only one pore per mesoporous oxide nanoparticle.

24. A method for delivering a molecular cargo to an individual comprising:

administering to an individual a composition comprising polyethylene-glycol (PEG) functionalized mesoporous oxide nanoparticles having an average size of 15 nm or less and having only one pore per mesoporous oxide nanoparticle, and at least 90% of the nanoparticles are within 3 nm of the average size, and at least a portion of the non-pore surface is at least partially functionalized with polyethylene glycol groups comprising a molecular cargo, wherein at least a portion of the molecular cargo is released in the individual.

25. The method of claim 24 , wherein the molecular cargo is a therapeutic agent or prophylactic agent.

26. The method of claim 24 , wherein at least 70% of the mesoporous oxide nanoparticles have only one pore per mesoporous oxide nanoparticle.

Assignments (2)
CONFIRMATORY LICENSE Recorded Apr 6, 2015
From: CORNELL UNIVERSITY
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 035366/0520 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 22, 2014
From: WIESNER, ULRICH; MA, KAI
To: CORNELL UNIVERSITY
Reel/Frame 034567/0001 →
Continuity (2)
Provisional Application 61662999 · Jun 22, 2012
Related Publication 20150366995A1 · Dec 24, 2015
Cited By (1)
US 12,201,956